September 23, 2025
AABB is pleased to announce the 2025 schedule for the Biotherapies Pavilion, part of the 2025 AABB Annual Meeting Exhibit Hall. The Biotherapies Pavilion offers attendees a mix of networking events, expert panels and interactive sessions to highlight advances across the cellular therapy and biotherapies landscape. The pavilion will feature open-mic discussions on topics ranging from cell collection innovations to organoid research, as well as opportunities for attendees to connect with colleagues and industry leaders.
Saturday, Oct. 25, 4:30 p.m. PT
Attendees can visit the Biotherapies Pavilion during the Exhibit Hall Opening Reception for a chance to receive a limited-availability Biotherapies Pavilion tote bag.
Sunday, Oct. 26, 9.30 a.m. PT
AABB invites current and future CABPs to a coffee morning to celebrate the Certified Advanced Biotherapies Professionals (CABP) Credentialing Program and newly credentialed professionals. Recent CABPs will discuss exam preparation, study resources and networking opportunities.
Sunday, Oct. 26, 10:30–11:15 a.m. PT
This open-mic discussion will explore emerging approaches to improve access, efficiency and quality in cell collection. Speakers from Terumo Blood and Cell Technologies, WellSky, and Accellix will share strategies for bringing collection closer to patients and encourage attendees to contribute to the discussion.
Sunday, Oct. 26, 3:30–4:15 p.m. PT
Speakers from Charles River Laboratories and Vitalant will lead a discussion on the importance of consistent and reliable sourcing of cellular starting material for investigational new drug (IND) success. This discussion will explore how proactive planning can reduce regulatory risk, support long-term trial execution and ensure supply continuity as programs advance.
Monday, Oct. 27, 12:45–1:15 p.m. PT
The Biotherapies Pavilion will host “Final CT Jeopardy!” following “Cell Therapy Lab Jeopardy.” Attendees can participate in a fast-paced bonus round, test their knowledge and compete for prizes.
Monday, Oct. 27, 2:30–3:15 p.m. PT
Speakers from Pluristyx and BioLife Solutions will discuss patient-derived organoids and their applications in drug discovery and cell therapy development. The session will address challenges in scale-up, standardization, biopreservation, logistics and regulatory pathways while encouraging attendees to share experiences and solutions.
AABB is also pleased to welcome Accesso Biotech. a developer of diagnostic and health sciences technologies, to the Biotherapies Pavilion at the 2025 AABB Annual Meeting.
Accesso Biotech is among several innovative companies and organizations participating in this year’s Biotherapies Pavilion. Additional participants include Accellix. BBG Advanced Therapies, Charles River Laboratories, Eurofins CellTx, FerroBio Technologies, J&J Innovative Medicine, Save the Cord Foundation, Terumo Blood and Cell Technologies, Versiti and Vitalant.
To spotlight participating organizations, AABB spoke with Robert Marriott, vice president of clinical and research quality services at Vitalant, about his organization and the changing landscape of biotherapies. AABB’s Biotherapies Pavilion web page includes spotlight interviews with this year’s participating organizations.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
